Navigating evidence-based recommendations for the management of systemic sclerosis

Area of Science:

• Rheumatology
• Pulmonology
• Clinical Guidelines

Background:

• Recent years have seen the publication of key management recommendations for systemic sclerosis (SSc).
• These include updated European Alliance of Associations for Rheumatology (EULAR) recommendations and British Society for Rheumatology (BSR) guidelines.
• Interstitial lung disease (ILD) is a frequent complication of SSc, necessitating specific management guidance.

Purpose of the Study:

• To compare and contrast recent SSc management guidelines from various organizations.
• To provide an overview of best practice, evidence-based management for SSc and SSc-ILD.
• To help clinicians navigate the evolving treatment landscape for SSc.

Main Methods:

• Comparative analysis of published guidelines from EULAR, BSR, American College of Chest Physicians (ACR), European Respiratory Society (ERS), and American Thoracic Society (ATS).
• Examination of methodological robustness, scope, and alignment of recommendations.
• Identification of overlaps, similarities, and differences in approaches to SSc and SSc-ILD management.

Main Results:

• EULAR and BSR guidelines are generally aligned but show differences in methodology and scope.
• Additional recommendations address SSc-ILD, with some guidelines covering broader systemic autoimmune rheumatic diseases.
• Multiple organizations, including ACR, ERS, EULAR, and ATS, have contributed to SSc-ILD recommendations.

Conclusions:

• A comprehensive comparison of guidelines offers valuable insights into evidence-based SSc and SSc-ILD management.
• Understanding the nuances between guidelines supports informed clinical decision-making.
• This review facilitates navigation of the complex and evolving treatment strategies for systemic sclerosis.